Fondazione IRCCS SDN, Naples, Italy.
PLoS One. 2011;6(11):e27722. doi: 10.1371/journal.pone.0027722. Epub 2011 Nov 15.
Many studies have shown that microRNA expression in cancer may be regulated by epigenetic events. Recently, we found that in lung cancer miR-212 was strongly down-regulated. However, mechanisms involved in the regulation of miR-212 expression are unknown. Therefore, we addressed this point by investigating the molecular mechanisms of miR-212 silencing in lung cancer. We identified histone modifications rather than DNA hypermethylation as epigenetic events that regulate miR-212 levels in NSCLC. Moreover, we found that miR-212 silencing in vivo is closely associated with the severity of the disease.
许多研究表明,癌症中的 microRNA 表达可能受到表观遗传事件的调控。最近,我们发现肺癌中的 miR-212 表达受到强烈下调。然而,miR-212 表达调控的机制尚不清楚。因此,我们通过研究肺癌中 miR-212 沉默的分子机制来解决这一问题。我们发现组蛋白修饰而非 DNA 高甲基化是调节 NSCLC 中 miR-212 水平的表观遗传事件。此外,我们发现体内 miR-212 沉默与疾病的严重程度密切相关。